Leukemia in twins: Lessons in natural history

Blood

Volumn 102, Issue 7, 2003, Pages 2321-2333

  Greaves, Mel F ^a   Maia, Ana Teresa ^b   Wiemels, Joseph L ^b   Ford, Anthony M ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; HYBRID PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; TEL AML1 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; CHIMERA; CHROMOSOME TRANSLOCATION; CLONAL VARIATION; DISEASE MARKER; EMBRYO DEVELOPMENT; ENVIRONMENTAL EXPOSURE; GENE DELETION; GENE FUNCTION; GENE FUSION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC MARKER; HUMAN; LEUKEMIA; LEUKEMOGENESIS; MOLECULAR GENETICS; MONOZYGOTIC TWINS; NEWBORN CARE; PRIORITY JOURNAL; PROGENY; RESTRICTION MAPPING; REVIEW;

EID: 0141482011     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3817     Document Type: Review

References (138)

1. Gedda L. Twins in History and Science. Springfield, IL: Charles C Thomas; 1961.
2. Wright L. Twins. New York, NY: Weidenfeld & Nicolson/Wiley; 1997.
3. Galton, F. The history of twins, as a criterion of the relative powers of nature and nurture. J Anthropol Inst Gr Br Ir. 1875;5:391-406.
4. Rende RD, Plomin R, Vandenberg SG. Who discovered the twin method? Behav Genet. 1990;20:277-285.
5. Hrubec Z, Robinette CD. The study of human twins in medical research. N Engl J Med. 1984;310:435-441.
6. Nance WE, ed. Twin Research, Part C: Clinical Studies. New York: Alan R Liss; 1978.
7. Reed TE, Chandler JH. Huntington's chorea in Michigan, I: demography and genetics. Am J Hum Genet. 1958;10:201-225.
8. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit Survey. Am Rev Respir Dis. 1978;117:621-624.
9. Cooke GS, Hill AVS. Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001;2:967-977.
10. Salvetti M, Ristori G, Bomprezzi R, Pozzilli P, Leslie RDG. Twins: mirrors of the immune system. Immunol Today. 2000;21:342-347.
11. Turner M, Barnby G, Bailey A. Genetic clues to the biological basis of autism. Mol Med Today. 2000;6:238-244.
12. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med. 1990;322:1483-1487.
13. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer. N Engl J Med. 2000;343:78-85.
14. McClearn GE, Johansson B, Berg S, et al. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science. 1997;276:1560-1563.
15. Roy M-A, Neale MC, Kendler KS. The genetic epidemiology of self-esteem. Br J Psychiatry. 1995;166:813-820.
16. Drayna D, Manichaikul A, de Lange M, Snieder H, Spector T. Genetic correlates of musical pitch recognition in humans Science. 2001;291:1969-1972.
17. Morahan G, Huang D, Ymer SI, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet. 2001;27:218-221.
18. Allen G. Twin research: problems and prospects. In: Steinberg AG, Beam AG, eds. Progress in Medical Genetics. Vol. IV. London, United Kingdom: William Heinemann Medical Books; 1965:242-269.
19. Senator H. Zur Kenntniss der Leukämie und Pseudoleukãmie im Kindesalter, Berliner Klinische: Wochenschrift. 1882;35:533-536.
20. Keith L, Brown E. Leukemia in twins. World-wide review of clinical cases. Acta Genet Med Gemellol. 1970;19:66-68.
21. Hitzig WH, Rampini S. Leukämie bei Zwillingen: Vier eigene Beobachtungen und Literaturübersicht. Helvet Paediat Acta. 1959;14:67.
22. MacMahon B, Levy MA. Prenatal origin of childhood leukemia. N Engl J Med. 1964;270:1082-1085.
23. Keith L, Brown E. Epidemiologic study of leukemia in twins (1928-1969). Acta Genet Med Gemellol. 1971;20:1-22.
24. Miller RW. Deaths from childhood leukemia and solid tumors among twins and other sibs in the United States, 1960-67. J Natl Cancer Inst. 1971;46:203-209.
25. Zuelzer WW, Cox DE, Genetics aspects of leukemia. Semin Hematol. 1969;228:228-249.
26. Biondi A, Cimino G, Pieters R, Pui C-H. Biological and therapeutic aspects of infant leukemia. Blood. 2000;96:24-33.
27. Keith L, Brown ER, Fields C, Stepto R. Age group differences of twins with leukemia. In: Dutcher RM, Chieco-Blanchi L, eds. Unifying Concepts of Leukemia, Bibl haemat, No. 39. Basel, Switzerland: Karger; 1973:1125-1135.
28. Hecht T, Henke M, Schempp W, Bross KJ, Löhr GW. Acute lymphoblastic leukemia in adult identical twins. Blut. 1988;56:261-264.
29. Dameshek W, Savitz HA, Arbor B. Chronic lymphatic leukemia in twin brothers aged fifty-six. JAMA. 1929;92:1348-1349.
30. Stobbe H, Taeschner H. Konkordantes Auftreten lymphatischer Leukämie bei einigen Zwillingen. Ztschr f d ges inn Med u d Grensgeb. 1952;7:736.
31. Gunz FW. The epidemiology and genetics of the chronic leukemias. Clin Haematol. 1977;6:3-20.
32. Mack TM, Cozen W, Shibata DK, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med. 1995;332:413-418.
33. Aricò M, Nichols K, Whitlock JA, et al. Familial clustering of Langerhans cell histiocytosis. Br J Haematol. 1999;107:883-888.
34. Buckley JD, Buckley CM, Breslow NE, Draper GJ, Roberson PK, Mack TM. Concordance for childhood cancer in twins. Med Pediatr Oncol. 1996;26:223-229.
35. Wolman IJ. Parallel responses to chemotherapy in identical twin infants with concordant leukemia. J Pediatr. 1962;60:91-96.
36. Clarkson B, Boyse EA. Possible explanation of the high concordance for acute leukaemia in monozygotic twins. Lancet. 1971;1:699-701.
37. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science. 1945;102:400-401.
38. Billingham RE, Brent L, Medawar PB. "Actively acquired tolerance" of foreign cells. Nature. 1953;172:603-606.
39. Strong SJ, Corney G. The Placenta in Twin Pregnancy. Oxford, United Kingdom: Pergamon Press; 1967.
40. van Dijk BA, Boomsma DI, de Man AJM. Blood group chimerism in human multiple births is not rare. Am J Med Genet. 1996;61:264-268.
41. Lopriore E, Vandenbussche FPHA, Tiersma ESM, de Beaufort AJ, de Leeuw JP. Twin-to-twin transfusion syndrome: new perspectives. J Pediatr. 1995;127:674-679.
42. Herlitz G. Zur Kenntnis der anämischen und polyzytmischen Zustnde bei Neugeborenen sowie des Icterus gravis neonatorum. Acta Paediatr. 1941;29:211-241.
43. Berger HM, de Waard F, Molenaar Y. A case of twin-to-twin transfusion in 1617. Lancet. 2000;356:847-848.
44. Sandberg AA, Cortner J, Takagi N, Moghadam MA, Crosswhite LH. Differences in chromosome constitution of twins with acute leukemia. N Engl J Med. 1963;275:809-812.
45. Whang-Peng J, Freireich EJ, Oppenheim JJ, Frei E III, Tjio JH. Cytogenetic studies in 45 patients with acute lymphocytic leukemia. J Natl Cancer Inst. 1969;42:881-897.
46. Hilton HB, Lewis IC, Trowell HR. C group trisomy in identical twins with acute leukemia. Blood. 1970;35:222-226.
47. Chaganti RSK, Miller DR, Meyers PA, German J. Cytogenetic evidence of the intrauterine origin of acute leukemia in monozygotic twins. N Engl J Med. 1979;300:1032-1034.
48. Hartley SE, Sainsbury C. Acute leukaemia and the same chromosome abnormality in monozygotic twins. Hum Genet. 1981;58:408-410.
49. Massaad L, Prieur M, Gaud C, Fischer A, Dutrillaux B. Unusual karyotypic evolution in subacute myelomonocytic leukemia in two monozygotic twins. Cancer Genet Cytogenet. 1989;38:205-213.
50. Richkind KE, Loew T, Meisner L, Harris C, Wason D. Identical cytogenetic clones and clonal evolution in pediatric monozygotic twins with acute myeloid leukemia: presymptomatic disease detection by interphase fluorescence in situ hybridization and review of the literature. J Pediatr Hematol Oncol. 1998;20:264-267.
51. Pombo de Oliveira MS, Awad El Seed FER, Foroni L, et al. Lymphoblastic leukaemia in Siamese twins: evidence for identity. Lancet. 1986;ii:969-970.
52. Greaves M, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3:639-649.
53. Reichel M, Gillert E, Nilson I, et al. Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation. Oncogene. 1998;17:3035-3044.
54. Wiemels JL, Alexander FE, Cazzaniga G, Biondi A, Mayer SP, Greaves M. Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2000;29:219-228.
55. Domer PH, Fakharzadeh SS, Chen C-S, et al. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci U S A. 1993;90:7884-7888.
56. Chen C-S, Medberry PS, Arthur DC, Kersey JH. Breakpoint clustering in t(4;11)(q21;q23) acute leukemia. Blood. 1991;78:2498-2504.
57. Morgan GJ, Cotter F, Katz FE, et al. Breakpoints at 11q23 in infant leukemias with the t(11;19)(q23;p13) are clustered. Blood. 1992;80:2172-2175.
58. Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature. 1993;363:358-360.
59. Gill Super HJ, Rothberg PG, Kobayashi H, Freeman AI, Diaz MO, Rowley JD. Clonal, nonconsitutional rearrangements of the MLL gene in infant twins with acute lymphoblastic leukemia: in utero chromosome rearrangement of 11q23. Blood. 1994;83:641-644.
60. Megonigal MD, Rappaport EF, Jones DH, et al. t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci U S A. 1998;95:6413-6418.
61. Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia. 1988;2:120-125.
62. Hill AVS, Jeffreys AJ. Use of minisatellite DNA probes for determination of twin zygosity at birth. Lancet. 1985;ii:1394-1395.
63. Romana SP, Mauchauffe M, Le Coniat M, et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood. 1995;85:3662-3670.
64. Golub TR, Barker GF, Bohlander SK, et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 1995;92:4917-4921.
65. Shurtleff SA, Buijs A, Behm FG, et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia. 1995;9:1985-1989.
66. UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. Br J Cancer. 2000;82:1073-1102.
67. Ford AM, Bennett CA, Price CM, Bruin MCA, Van Wering ER, Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A. 1998:95:4584-4588.
68. Mala AT, Ford AM, Jalali GR, et al. Molecular tracking of leukemogenesis in a triplet pregnancy. Blood. 2001;98:478-482.
69. Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood. 1999;94:1057-1062.
70. Wiemels JL, Cazzaniga G, Daniotti M, et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet. 1999;354:1499-1503.
71. Ford AM, Pombo-de-Oliveira MS, McCarthy KP, et al. Monoclonal origin of Concordant T-cell malignancy in identical twins. Blood. 1997;89:281-285.
72. Maia AT, van der Velden VHJ, Harrison CJ, et al. Pre-natal origin of hyperdiploid acute lymphoblastic leukemia in identical twins. Leukemia. In press.
73. Kempski H, Mensa-Bonsu KA, Keamey L, et al. Prenatal chromosomal diversification of leukaemia in monozygotic twins. Genes Chromosomes Cancer. 2003;37:406-411.
74. Zuna J, Muzikova K, Ford AM, et al. Pre-natal, clonal origin of acute lymphoblastic leukaemia in triplets. Leuk Lymphoma. In press.
75. Van den Berghe H, David G, Broeckert-Van Orskoven A, et al. A new chromosome anomaly in acute lymphoblastic leukemia (ALL). Hum Genet. 1979;46:173-180.
76. Ridge SA, Cabrera ME, Ford AM, et al. Rapid intraclonal switch of lineage dominance in congenital leukaemia with a MLL gene rearrangement. Leukemia. 1995;9:2023-2026.
77. Hunger SP, McGavran L, Meltesen L, Parker NB, Kassenbrock CK, Bitter MA. Oncogenesis in utero: fetal death due to acute myelogenous leukaemia with an MLL translocation. Br J Haematol. 1998;103:539-542.
78. Falletta JM, Starling KA, Fembach DJ. Leukemia in twins. Pediatrics. 1973;52:846-849.
79. Guthrie R, Susi A. A simple phenylalanine method for the detection of phenylketonuria in large populations of new-born infants. Pediatrics. 1963;32:338-341.
80. Jinks DC, Minter M, Tarver DA, Vanderford M, Hejtmancik JF, McCabe ERB. Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Hum Genet. 1989;81:363-366.
81. Comeau AM, Hsu H-W, Schwerzier M, et al. Identifying human immunodeficiency virus infection at birth: application of polymerase chain reaction to Guthrie cards. J Pediatr. 1993;123:252-258.
82. Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A. 1997;94:13950-13954.
83. Fasching K, Panzer S, Haas OA, Marschalek R, Gadner H, Panzer-Grümayer ER. Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. Blood. 2000;95:2722-2724.
84. Yagi T, Hibi S, Tabata Y, et al. Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood. 2000;96:264-268.
85. Taub JW, Konrad MA, Ge Y, et al. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood. 2002;99:2992-2996.
86. Panzer-Grümayer ER, Fasching K, Panzer S, et al. Nondisjunction of chromosomes leading to hyperdiploid childhood B-cell precursor acute lymphoblastic leukemia is an early event during leukemogenesis. Blood. 2002;100:347-349.
87. Wiemels JL, Xiao Z, Buffler PA, et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood. 2002;99:3801-3805.
88. Wiemels JL, Leonard B, Wang Y, et al. Specific translocation and evidence of post-natal origin of the t(1;19) E2A-PBX1 translocation in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2002;99:15101-15106.
89. Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene. 2001;20:5695-5707.
90. Bloomfield CD, Archer KJ, Mrózek K, et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer. 2002;33:362-878.
91. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J. 1997;16:4226-4237.
92. Lavau C, Luo RT, Du C, Thirman MJ. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice. Proc Natl Acad Sci U S A. 2000;97:10984-10989.
93. Dobson CL, Warren AJ, Pannell R, et al. The MII-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis. EMBO J. 1999;18:3564-3574.
94. Schulte CE. von Lindern M, Steinlein P, Beug H, Wiedemann LM. MLL-ENL cooperates with SCF to transform primary avian multipotent cells. EMBO J. 2002;21:4297-4306.
95. Lanza C, Gaidano G, Cimino G, et al. Distribution of TP53 mutations among acute leukemias with MLL rearrangements. Genes Chromosomes Cancer. 1996;15:48-53.
96. Mahgoub N, Parker RI, Hosler MR, et al. RAS mutations in pediatric leukemias with MLL gene rearrangements. Genes Chromosomes Cancer. 1998;21:270-275.
97. Armstrong SA, Kung AL, Mabon ME, et al. Inhibition of FLT3 in MLL: validation of a therapeutic target identified by gene expression based classification. Cancer Cell. 2003;3:173-183.
98. Andreasson P, Schwaller J, Anastasiadou E, Aster J, Gilliland DG. The expression of ETV6/CBF2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet. 2001;130:93-104.
99. Bernardin F, Yang Y, Cleaves R, et al. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res. 2002;62:3904-3908.
100. Yuan Y, Zhou L, Miyamoto T, et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci U S A. 2001;98:10398-10403.
101. Higuchi M, O'Brien D, Kumaravelu P, Lenny N, Yeoh E-J, Downing JR. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell. 2002;1:63-74.
102. Raynaud S, Cavé H, Baens M, et al. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood. 1996;87:2891-2899.
103. Cavé H, Cacheux V, Raynaud S, et al. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphoblastic leukemia. Leukemia. 1997;11:1459-1464.
104. McLean TW, Ringold S, Neuberg D, et al. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood. 1996;88:4252-4258.
105. Van Rompaey L, Potter M, Adams C, Grosveld G. Tel induces a G1 arrest and suppresses Ras-induced transformation. Oncogene. 2000;19:5244-5250.
106. Lopez RG, Carron C, Oury C, Gardellin P, Bernard O, Ghysdael J. TEL is a sequence-specific transcriptional repressor. J Biol Chem. 1999;274:30132-30138.
107. Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard OA, Berger R. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia. 1996;10:167-170.
108. Ford AM, Fasching K, Panzer-Grümayer ER, Koenig M, Haas OA, Greaves MF. Origins of "late" relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood. 2001;98:558-564.
109. Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer. 2002;2:502-513.
110. Knudson AG. Stem cell regulation, tissue ontogeny, and oncogenic events. Semin Cancer Biol. 1992;3:99-106.
111. Mori H, Colman SM, Xiao Z, et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci U S A. 2002;99:8242-8247.
112. Biemaux C, Loos M, Sels A, Huez G, Stryckmans P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood. 1995;86:3118-3122.
113. Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood. 1998;92:3362-3367.
114. Uckun FM, Herman-Hatten K, Crotty M-L, et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood. 1998;92:810-821.
115. Kim-Rouillé M-H, MacGregor A, Wiedemann LM, Greaves MF, Navarrete C. MLL-AF4 gene fusions in normal newborns. Blood. 1999;93:1107-1108.
116. Trka J, Zuna J, Hrusak O, Michalova K, Kalinova M, Stary J. No evidence for MLL-AF4 expression in normal cord blood samples. Blood. 1999;93:1106-1107.
117. Yamamoto S, Zaitsu M, Ishii E, et al. High frequency of fusion transcripts of exon 11 and exon 4/5 in AF-4 gene is observed in cord blood, as well as leukemic cells from infant leukemia patients with t(4;11)(q21;q23). Leukemia. 1998;12:1392-1403.
118. Greaves M, Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Can. 1999;35:173-185.
119. Felix CA. Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta. 1998;1400:233-255.
120. Ross JA, Potter JD, Robison LL. Infant leukemia, topoisomerase II inhibitors, and the MLL gene. J Natl Cancer Inst. 1994;86:1678-1680.
121. Strissel PL, Strick R, Rowley JD, Zeleznik-Le NJ. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood. 1998;92:3793-3803.
122. Cimino G, Rapanotti MC, Biondi A, et al. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res. 1997;57:2879-2883.
123. Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci U S A. 2000;97:4790-4795.
124. Wiemels JL, Pagnamenta A, Taylor GM, Eden OB, Alexander FE, Greaves MF, Investigators UCCS. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. Cancer Res. 1999;59:4095-4099.
125. Smith MT, Wang Y, Skibda CF, et al. Low NAD(P)H: quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood. 2002;100:4590-4593.
126. Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control. 1996;7:581-590.
127. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukaemia with MLL gene fusion. Cancer Res. 2001;61:2542-2546.
128. Sharpe CR, Franco EL. Use of dipyrone during pregnancy and risk of Wilms' tumor. Epidemiology. 1996;7:533-535.
129. Greaves MF. Aetiology of acute leukaemia. Lancet. 1997;349:344-349.
130. Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ. Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. Int J Epidemiol. 2001;30:1428-1437.
131. Perrillat F, Clavel J, Auclerc MF, et al. Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study. Br J Cancer. 2002;86:1064-1069.
132. Ma X, Buffler PA, Selvin S, et al. Daycare attendance and risk of childhood acute lymphoblastic leukaemia. Br J Cancer. 2002;86:1419-1424.
133. Taylor GM, Dearden S, Ravetto P, et al, UKCCS Investigators. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201. Hum Mol Genet. 2002;11:1585-1597.
134. Thompson JR, Fitz Gerald P, Willoughby MLN, Armstrong BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet. 2001;358:1935-1940.
135. Wiemels JL, Smith RN, Taylor GM, et al, UK Childhood Cancer Study Investigators. Methylene tetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A. 2001;98:4004-4009.
136. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94:3290-3295.
137. Campbell M, Cabrera ME, Legues ME, Ridge S, Greaves M. Discordant clinical presentation and outcome in infant twins sharing a common clonal leukaemia. Br J Haematol. 1996;93:166-169.
138. Hemminki K, Jiang Y. Risks among siblings and twins for childhood acute lymphoid leukaemia: results from the Swedish Family-Cancer Database. Leukemia. 2002;16:297-298.